ID
28042
Descrição
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Eligibility Question
Palavras-chave
Versões (4)
- 27/08/2017 27/08/2017 -
- 13/10/2017 13/10/2017 -
- 23/10/2017 23/10/2017 -
- 12/12/2017 12/12/2017 -
Titular dos direitos
GlaxoSmithKline
Transferido a
12 de dezembro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Question GSK study Chronic Coronary Heart Disease NCT00799903
Eligibility Question GSK study Chronic Coronary Heart Disease NCT00799903
Descrição
Inclusion Criteria
Descrição
Subject must understand the aims, investigational procedures and possible consequences of the study).
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0021430
Descrição
Refer to Appendix 1: Highly Effective Methods For Avoidance Of Pregnancy In Women Of Childbearing Potential. The decision to include or exclude women of childbearing potential may be made at the discretion of the investigator in accordance with local practice in relation to adequate contraception.
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C0150831
- UMLS CUI [1,2]
- C0001779
Descrição
statin therapy
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0360714
Descrição
Chronic CHD documented by at least one of the following: a. prior MI (>1 month prior to randomisation). b. prior coronary revascularization procedure [percutaneous coronary intervention (PCI) > 1 month prior to randomization or coronary artery bypass graft (CABG) >3 months prior to randomization]. c. multivessel CHD involving major epicardial coronary arteries confirmed by coronary angiography at any time (without revascularization).
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0010068
Descrição
At least one of the following additional predictors of CV risk [a through f]: a. age >60 years at randomization. b. diabetes mellitus requiring pharmacothearpy. c. HDL-C <40 mg/dL (1.03 mmol/L). d. smoker (defined as at least 5 cigarettes per day on average) or a previous smoker (defined as at least 5 cigarettes per day on average when smoking) who discontinued within the past 3 months. e. significant renal dysfunction (defined as estimated glomerular filtration rate [eGFR] >30 and <59 mL/min per 1.73 m2 OR urine ACR >30 mg albumin/g creatinine). f. polyvascular disease manifested as coexistent clinically diagnosed arterial disease in at least 2 arterial territories, defined as: > chronic CHD and cerebrovascular disease defined as carotid artery disease or prior ischemic stroke >3 months. OR > chronic CHD and peripheral arterial disease (PAD).
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0850624
Descrição
Exclusion Criteria
Descrição
Planned coronary revascularization
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0877341
Descrição
Current liver disease, known hepatic or biliary abnormalities (with the exception of Gilbert's syndrome or asymptomatic gallstones) or evidence of abnormal liver function test [total bilirubin or alkaline phosphatase >1.5 x upper limit of normal (ULN); or ALT or AST >2.5 x ULN] or other hepatic abnormalities that in the opinion of the Investigator would preclude the subject from participation in the study.
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0023895
Descrição
renal impairment
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C1565489
Descrição
heart failure
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0018801
Descrição
hypertension
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0020538
Descrição
(e.g., very severe chronic airways disease, known human immunodeficiency virus [HIV] positive, or cancer in the past five years other than non-melanoma skin cancer).
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C2826244
- UMLS CUI [1,2]
- C0012634
Descrição
asthma
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0004096
Descrição
All female subjects of childbearing potential must have a urine ß?-human chorionic gonadotropin [hCG] pregnancy test performed at Screening and/or within 7 days prior to randomization.
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0032961
Descrição
Refer to Appendix 2: Clinical criteria for diagnosing anaphylaxis [Sampson, 2006]
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0002792
Descrição
Alcohol or drug abuse
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0038586
Descrição
intake CYP3A4 inhibitors
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C3830624
Descrição
Lp-PLA2 activity
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0031671
Descrição
exposure to darapladib
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C2348075
Descrição
Use of another investigational product
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0304229
Descrição
study of investigational device
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C2346570
Descrição
other reason for exclusion
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C0680251
- UMLS CUI [1,2]
- C3840932
Similar models
Eligibility Question GSK study Chronic Coronary Heart Disease NCT00799903
C0001779 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])
C3840932 (UMLS CUI [1,2])